Lista de obras - Olli Kampman - Dominio Público Uruguay

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

artículo científico publicado en 2009

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression.

artículo científico publicado en 2014

ACE polymorphism and response to electroconvulsive therapy in major depression

artículo científico publicado en 2009

Acute Psychogeriatric Inpatient Treatment Improves Neuropsychiatric Symptoms but Impairs the Level of Functioning in Patients with Dementia

artículo científico publicado en 2015

Anxiety Disorders and Temperament-an Update Review

artículo científico publicado en 2017

Apolipoprotein E polymorphism is associated with age of onset in schizophrenia

artículo científico publicado en 2004

Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach

artículo científico publicado en 2007

Association between folate intake and melancholic depressive symptoms. A Finnish population-based study

artículo científico publicado en 2012

Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia

scientific article published on 14 September 2006

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study

artículo científico publicado en 2013

Association of EGF polymorphism with schizophrenia in Finnish men.

artículo científico publicado en 2004

Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire

artículo científico publicado en 2000

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

artículo científico publicado en 2018

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

artículo científico publicado en 2013

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

artículo científico publicado en 2014

Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis.

artículo científico publicado en 2011

Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia

artículo científico publicado en 2003

Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia

scientific article published on 01 June 2007

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

artículo científico publicado en 2010

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

artículo científico publicado en 2014

Dopamine receptor D2 -141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia

artículo científico publicado en 2003

Early assessment of implementing evidence-based brief therapy interventions among secondary service psychiatric therapists

artículo científico publicado en 2015

Effects of S-Ketamine as an Anesthetic Adjuvant to Propofol on Treatment Response to Electroconvulsive Therapy in Treatment-Resistant Depression ⬇️

artículo científico publicado el 1 de septiembre de 2013

Efficacy of electroconvulsive therapy: is it in the BDNF gene?

artículo científico publicado en 2013

Factors associated with subjective side-effects during clozapine treatment

artículo científico publicado en 2014

Four-year outcome in non-compliant schizophrenia patients treated with or without home-based ambulatory outpatient care

artículo científico publicado en 2003

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

artículo científico publicado en 2018

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

artículo científico publicado en 2017

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

artículo científico publicado en 2016

Indicators of medication compliance in first-episode psychosis

scientific article published on 01 May 2002

Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics

artículo científico publicado en 2004

Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics

artículo científico publicado en 2003

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

artículo científico publicado en 2011

Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia

artículo científico publicado en 2004

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

artículo científico publicado en 2010

Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics

artículo científico publicado en 2004

Leisure-time physical activity and metabolic syndrome plus depressive symptoms in the FIN-D2D survey

artículo científico publicado en 2010

Lifetime leisure-time physical activity and the risk of depressive symptoms at the ages of 65-74 years: the FIN-D2D survey

artículo científico publicado en 2012

Meta-analysis of anxiety disorders and temperament

artículo científico publicado en 2014

NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia

artículo científico publicado en 2003

Neuregulin genotype and medication response in Finnish patients with schizophrenia

scientific article published on 01 November 2004

No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin

artículo científico publicado en 2013

One-year follow-up after discontinuing maintenance electroconvulsive therapy

artículo científico publicado en 2012

Outcome of patients with dual diagnosis in secondary psychiatric care.

artículo científico publicado en 2016

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

artículo científico publicado en 2011

Patient characteristics and diagnostic discrepancy in first-episode psychosis

scientific article published on 01 May 2004

Pessimism and risk of death from coronary heart disease among middle-aged and older Finns: an eleven-year follow-up study.

artículo científico publicado en 2016

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment

artículo científico publicado en 2014

Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study

artículo científico publicado en 2011

Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis

artículo científico publicado en 2015

RGS4 genotype is not associated with antipsychotic medication response in schizophrenia

artículo científico publicado en 2006

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

artículo científico publicado en 2008

Relationships between depressive symptoms and self-reported unintentional injuries: the cross-sectional population-based FIN-D2D survey

artículo científico publicado en 2012

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

artículo científico publicado en 2016

SERT and NET polymorphisms, temperament and antidepressant response

artículo científico publicado en 2015

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression

artículo científico publicado en 2015

Smoking and weight among patients using clozapine

artículo científico publicado en 2014

Socioeconomic factors and use of psychotherapy in common mental disorders predisposing to disability pension

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

artículo científico publicado en 2009

TPH1 A218C polymorphism and temperament in major depression

artículo científico publicado en 2013

Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse.

artículo científico publicado en 2016

Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression

artículo científico publicado en 2010

Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients ⬇️

artículo científico publicado el 8 de octubre de 2010

The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients

artículo científico publicado en 2018

The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings

artículo científico publicado en 2001

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

artículo científico publicado en 2010

[Compliance with treatment in schizophrenia and mood disorders]

artículo científico publicado en 2000

[Is antipsychotic drug therapy predictable?]

artículo científico publicado en 2005

Lista de obras de Olli Kampman

5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.

A cluster model of temperament as an indicator of antidepressant response and symptom severity in major depression.

ACE polymorphism and response to electroconvulsive therapy in major depression

Acute Psychogeriatric Inpatient Treatment Improves Neuropsychiatric Symptoms but Impairs the Level of Functioning in Patients with Dementia

Anxiety Disorders and Temperament-an Update Review

Apolipoprotein E polymorphism is associated with age of onset in schizophrenia

Association between 5-HT2A, TPH1 and GNB3 genotypes and response to typical neuroleptics: a serotonergic approach

Association between folate intake and melancholic depressive symptoms. A Finnish population-based study

Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia

Association between vitamin b12 levels and melancholic depressive symptoms: a Finnish population-based study

Association of EGF polymorphism with schizophrenia in Finnish men.

Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression

BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression

CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine

Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis.

Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia

Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine

Dopamine receptor D2 -141C Insertion/Deletion polymorphism in a Finnish population with schizophrenia

Early assessment of implementing evidence-based brief therapy interventions among secondary service psychiatric therapists

Effects of S-Ketamine as an Anesthetic Adjuvant to Propofol on Treatment Response to Electroconvulsive Therapy in Treatment-Resistant Depression ⬇️

Efficacy of electroconvulsive therapy: is it in the BDNF gene?

Factors associated with subjective side-effects during clozapine treatment

Four-year outcome in non-compliant schizophrenia patients treated with or without home-based ambulatory outpatient care

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine

Indicators of medication compliance in first-episode psychosis

Interaction between NOTCH4 and catechol-O-methyltransferase genotypes in schizophrenia patients with poor response to typical neuroleptics

Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics

Interaction between two HTR2A polymorphisms and gender is associated with treatment response in MDD.

Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?

Lack of association between two polymorphisms of brain-derived neurotrophic factor and response to typical neuroleptics

Leisure-time physical activity and metabolic syndrome plus depressive symptoms in the FIN-D2D survey

Lifetime leisure-time physical activity and the risk of depressive symptoms at the ages of 65-74 years: the FIN-D2D survey

Meta-analysis of anxiety disorders and temperament

NOTCH4 gene promoter polymorphism is associated with the age of onset in schizophrenia

Neuregulin genotype and medication response in Finnish patients with schizophrenia

No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin

One-year follow-up after discontinuing maintenance electroconvulsive therapy

Outcome of patients with dual diagnosis in secondary psychiatric care.

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.

Patient characteristics and diagnostic discrepancy in first-episode psychosis

Pessimism and risk of death from coronary heart disease among middle-aged and older Finns: an eleven-year follow-up study.

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment

Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study

Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis

RGS4 genotype is not associated with antipsychotic medication response in schizophrenia

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

Relationships between depressive symptoms and self-reported unintentional injuries: the cross-sectional population-based FIN-D2D survey

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine

SERT and NET polymorphisms, temperament and antidepressant response

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression

Smoking and weight among patients using clozapine

Socioeconomic factors and use of psychotherapy in common mental disorders predisposing to disability pension

TPH1 218A/C polymorphism is associated with major depressive disorder and its treatment response

TPH1 A218C polymorphism and temperament in major depression

Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse.

Temperament profiles, 5-HT2A genotype, and response to treatment with SSRIs in major depression

Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients ⬇️

The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients

The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings

Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression

[Compliance with treatment in schizophrenia and mood disorders]

[Is antipsychotic drug therapy predictable?]